CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 225 enrolled
Drug / intervention
CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00984308
NCT00984308Phase 3Completed
CompareCT.gov

Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease

VA Office of Research and Development·interventional·Posted Sep 25, 2009·Updated Jun 14, 2017

In Brief

A Phase 3 clinical trial evaluating CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) for Obstructive Sleep Apnea and 3 related conditions. Completed, enrolled 225 participants across 2 sites.

Detailed Summary

Sleep apnea is common among Veterans with cerebrovascular disease (stroke or transient ischemic attack \[TIA\]), leads to hypertension, and is associated with recurrent stroke and death. Although continuous positive airway pressure (CPAP) safely treats sleep apnea, few Veterans with cerebrovascular disease are diagnosed with sleep apnea or offered treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea, Stroke, Transient Ischemic Attack, Hypertension
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 25, 2009
Enrollment StartDec 23, 2008
Primary CompletionSep 30, 2011
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 16.8 years ago

Interventions

CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)procedure

Continuous Positive Airway Pressure (CPAP) is provided for those patients who are diagnosed with OSA.